Dr. Kathleen Murphy outlines new tools for diagnosis and prognosis of melanoma and how this can be applied to personalized medicine.
Published
August 16, 2021
Created by
Related Presenters
Director, Molecular Diagnostics
Chief Laboratory Officer
ProPath
Dr. Kathleen Murphy completed graduate school at the University of Louisville studying Microbiology and Immunology. She then completed her fellowship studies at Johns Hopkins University School of Medicine focusing on Molecular Pathology.